Skip to content
Insider tapeLive · 5:07 PM ET
My stocks

Ourania Tatsis

At a glance: Ourania Tatsis is Evp, Chief Reg. & Quality Off. at Vertex Pharmaceuticals (VRTX). Their latest SEC Form 4, filed Jul 7, 2026, reported a sale of $787K. On file: 0 purchase lines ($0) and 8 sale lines ($6.5M).

Disclosed holdings: about $23.6M of VRTX stock: 45,321 shares reported on their latest Form 4 (filed Jul 7, 2026), valued at the Nov 19, 2026 close of $521.30. This counts only VRTX shares reported to the SEC; it leaves out cash, other investments, options and unvested awards, so it is not total net worth.

Evp, Chief Reg. & Quality Off. at Vertex Pharmaceuticals Inc / Ma (VRTX)

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $6.5M

Ourania Tatsis's InsiderPrint

8 trades from SEC Form 4 filings, 2025 to 2026, drawn as one fingerprint.

InsiderPrint of Ourania Tatsis: 8 trades, 2025 to 20262025: 0 buys, 1 sale2026: 0 buys, 7 sales

Reading this print: Almost only sells, trading about 8 times a year, typically $750K a trade; most sales are on a pre-planned 10b5-1 schedule; trades in the same month most years.

  • Bump outward: a purchase (0)
  • Dent inward: a sale (8)
  • One ring per year, oldest in the middle, Jan at the top going clockwise. Bigger bumps mean more dollars.

Insiders with a similar print

  1. Gary TrainorDirector · PAY · 100% match
  2. Fiona TanCTO · W · 100% match
  3. Elena BuninaDirector · NBIS · 100% match
  4. Kevin J. YeamanCEO, President · DLB · 100% match
  5. Rene A. LacerteCEO · BILL · 100% match

Matched on seven traits of each insider's trading pattern (buy share, pace, typical size, planned sales, seasonality, buying after drops, number of companies). Pattern matching on public filings; history, not a prediction.

Reported trades

Filed Stock Type Shares Price Value Since
Jul 7SEC VRTXVertex Pharmaceuticals Inc / Ma Sell Plan 1,50045,321 held (−3%) $524.99 $787K -0.7%
Feb 26SEC VRTXVertex Pharmaceuticals Inc / Ma Sell Plan 26046,763 held (−1%) $486.35 $126K +7.2%
Feb 19SEC VRTXVertex Pharmaceuticals Inc / Ma Sell Plan 60949,018 held (−1%) $489.46 $298K +6.5%
Feb 19SEC VRTXVertex Pharmaceuticals Inc / Ma Sell Plan 36848,650 held (−1%) $473.68 $174K +10.1%
Feb 18SEC VRTXVertex Pharmaceuticals Inc / Ma Sell Plan 1,50046,132 held (−3%) $499.99 $750K +4.3%
Feb 12SEC VRTXVertex Pharmaceuticals Inc / Ma Sell Plan 46651,436 held (−1%) $460.43 $215K +13.2%
Jan 9SEC VRTXVertex Pharmaceuticals Inc / Ma Sell Plan 4,50042,293 held (−10%) $474.99 $2.1M +9.8%
Dec 5SEC VRTXVertex Pharmaceuticals Inc / Ma Sell Plan 4,50046,793 held (−9%) $449.99 $2.0M +15.8%
  • Sell

    Evp, Chief Reg. & Quality Off. Ourania Tatsis sold $787K of VRTX at $524.99 — pre-scheduled 10b5-1 plan sale.

  • Sell

    Evp, Chief Reg. & Quality Off. Ourania Tatsis sold $126K of VRTX at $486.35 — pre-scheduled 10b5-1 plan sale.

  • Sell

    Evp, Chief Reg. & Quality Off. Ourania Tatsis sold $298K of VRTX at $489.46 — pre-scheduled 10b5-1 plan sale.

  • Sell

    Evp, Chief Reg. & Quality Off. Ourania Tatsis sold $174K of VRTX at $473.68 — pre-scheduled 10b5-1 plan sale.

  • Sell

    Evp, Chief Reg. & Quality Off. Ourania Tatsis sold $750K of VRTX at $499.99 — pre-scheduled 10b5-1 plan sale.

  • Sell

    Evp, Chief Reg. & Quality Off. Ourania Tatsis sold $215K of VRTX at $460.43 — pre-scheduled 10b5-1 plan sale.

Follow Ourania Tatsis

Get one email when Ourania Tatsis files a new purchase or sale. Free.

At most one email a day about Ourania Tatsis, plus the free Monday email. Already subscribed? Use the same email to add them. Unsubscribe anytime. Facts from public filings, not advice.